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*Editor*

Globally, an estimated 28 400 000 operations have been cancelled or postponed during the peak 12 weeks of the COVID outbreak[^1^](#bjs11857-bib-0001){ref-type="ref"}. The recent decline in COVID‐19 cases with increased critical care bed availability and inpatient beds has led to planning safe resumption of elective services, including surgery[^2^](#bjs11857-bib-0002){ref-type="ref"}, [^3^](#bjs11857-bib-0003){ref-type="ref"}. The challenge to reintroduce elective surgery is to minimise the risk of patients contracting COVID‐19 as a result of undergoing surgery due to the risks of COVID‐19 related post‐operative mortality while trying to limit harm to the patient from the underlying condition by deferring or delaying surgery[^4^](#bjs11857-bib-0004){ref-type="ref"}, [^5^](#bjs11857-bib-0005){ref-type="ref"}. Guidance from the Colleges of Surgery in the United Kingdom and the NHS in April have recommended patients to be prioritised for elective surgery by a combination of clinical urgency of the condition requiring surgery and the vulnerability to COVID‐19 with equal measure[^6^](#bjs11857-bib-0006){ref-type="ref"}.

The Elective Surgery COVID‐19 Prioritisation (ESCOP MDT) was created at out trust to aid in the process of prioritising patients based on clinical urgency and vulnerability to COVID‐19 related mortality to provide transparency in the decision‐making process. The MDT core members include a nominated chair for the MDT, consultants with different sub‐speciality interests to prioritise clinical urgency of the different conditions (*e.g*. in general surgery ‐ upper and lower gastrointestinal surgeons with input from the breast, endocrine and vascular surgeons if required), a nominated speciality manager is responsible for updating the Patient Tracking List and a nominated clinician (consultant or senior registrar) is responsible for documenting the outcomes of the MDT in a form accessible to all members of the team (*e.g*. an electronic letter). Extended membership, by invitation on a case to case basis, may include anaesthetists, physicians and safeguarding nurse. The MDT is an advisory body and the autonomy of the responsible consultant is retained as the clinical responsibility for each patient sits with the consultant. Therefore, any concerns by the named responsible consultants with the MDT outcome will be addressed in the MDT with the consultant invited to it. The MDT process is outlined in *(Fig*. [*1*](#bjs11857-fig-0001){ref-type="fig"} *)*.

![Elective Surgery COVID‐19 Prioritisation MDT (ESCOP MDT). **\^Priority graded as 2 (surgery under 4 weeks), 3 (surgery under 3 months) or 4 (surgery over 4 months)** [^6^](#bjs11857-bib-0006){ref-type="ref"} **. \^\^COVID‐19 risk graded as A (severe risk), B (moderate risk) and C (low risk)** [^7^](#bjs11857-bib-0007){ref-type="ref"}.](BJS-9999-na-g001){#bjs11857-fig-0001}

The patient waiting list (also referred to as the patient tracking list (PTL) is initially screened by a clinician to prioritise the waiting list based on clinical urgency from the underlying condition. Patients are then discussed in the ESCOP MDT in this order of urgency. A composite score is allocated to each patient based on clinical priority (from 2‐ 4)[^6^](#bjs11857-bib-0006){ref-type="ref"} and COVID‐19 related risk (A‐C)[^7^](#bjs11857-bib-0007){ref-type="ref"}. Additionally, the MDT would recommend patients identified to have high COVID‐19 related vulnerability (A) to be contacted directly by the responsible consultants to have a frank discussion about the risks and merits of surgery and alternatives.

The establishment of this MDT parallels to the establishment of a Green pathway for the resumption of elective surgery at our trust, and both processes will be subjected to constant scrutiny to help grow and respond to the ongoing challenges posed.
